Bryan C. Cressey - May 24, 2021 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role: Director
Signature: /s/ Michael E. Tarvin, as attorney-in-fact
Stock symbol: SEM
Transactions as of: May 24, 2021
Transactions value $: -$399,000
Form type: 4
Date filed: 5/26/2021, 05:12 PM
Next filing: May 28, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEM	Common Stock	Sale	-$399K	-10K	-10%	$39.90	90K	May 24, 2021	By the Bryan Cressey and Iliana Sweis Cressey Foundation	F1, F2
holding	SEM	Common Stock						53.8K	May 24, 2021	Direct
holding	SEM	Common Stock						384K	May 24, 2021	By Cressey Investments LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.90 to $39.98, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.90 to $39.98, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.